News

Phase 1/2 trial to be HOOKIPA’s first clinical trial in immuno-oncology

Mitosis is the process by which the genetic information encoded on chromosomes is equally distributed to two daughter cells, a fundamental feature of...

11 Jul'19

An international team led by Jijie Chai and Cyril Zipfel that included PhD Student Katarzyna Parys and Youssef Belkhadir from the GMI identified a...

10 Jul'19

Together with Corinna Dawid from the Technical University of Munich, Youssef received this award for their work on how plants use essential fatty...

04 Jul'19

The patent strengthens the unique position of ARESdb, Ares Genetics’ knowledge base of antimicrobial resistance genetics.

02 Jul'19

Upon infection cells manage to quickly switch from normal operation to immune reaction in a matter of minutes. This innate immunity requires a...

02 Jul'19

IP Protection for Scarletred®Vision in the EU, USA, Japan and Australia.

01 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

01 Jul'19

Investors provided further €1.5 million in equity investments to support phage therapy to tackle the antibiotics crisis.

28 Jun'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

27 Jun'19

A two-days workshop focused on practical use of bio.tools, a comprehensive registry of research software and databases led by the guest lecturer Radka...

20 Jun'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

Centrioles - critical players in cell division

A Novel Mechanism for the Perception of Plant Peptide Hormones

GMI Group Leader Youssef Belkhadir received the Science Award Weihenstephan of the City of Freising

Ares Genetics is granted key European patent on genetic resistance testing

How cells quickly activate innate immunity

SCARLETRED: Patents granted in Japan and Australia

Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15

PhagoMed Biopharma GmbH successfully completed another financing round.

Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting

bio.tools - a comprehensive database of life sciences software

Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D